{"prompt": "['2017N331008_06', 'CONFIDENTIAL', '208090', 'Urinalysis', 'PARAMETER', 'GRADE', 'GRADE', 'GRADE 3', 'GRADE 4', '1', '2', 'SEVERE', 'POTENTIALLY', 'MILD', 'MODERATE', 'LIFE-', 'THREATENIN', 'Glycosuria', 'Trace to 1+ or', '2+ or > 250 to', '> 2+ or > 500 mg', 'NA', '(random', 'VI 250 mg', 'VI 500 mg', 'collection tested', 'by dipstick)', 'Hematuria (not', '6 to < 10 RBCs', '10 RBCs per', 'Gross, with or', 'Life-', 'to be reported', 'per high power', 'high power field', 'without clots', 'threatening', 'based on dipstick', 'field', 'OR With RBC', 'consequences', 'findings or on', 'casts OR', 'blood believed to', 'Intervention', 'be of menstrual', 'indicated', 'origin)', 'Proteinuria', '1+', '2+', '3+ or higher', 'NA', '(random', 'collection tested', 'by dipstick)', 'Appendix A: Total Bilirubin Table for Term and Preterm Neonates', 'PARAMETER', 'GRADE', 'GRADE', 'GRADE 3', 'GRADE 4', '1', '2', 'SEVERE', 'POTENTIALLY', 'MILD', 'MODERATE', 'LIFE-', 'THREATENIN', 'Total Bilirubin 18', ',', 'High', '(mg/dL;', 'mol/L) 19', '4 to < 7', '7to<10', '10 to < 17', ' 17', '68.4 to < 119.7', '119.7 to < 171', '171 to < 290.7', '> 290.7', 'Term Neonate20', '< 24 hours of', 'age', '24 to < 48', '5 to < 8', '8 to < 12', '12 to < 19', '> 19', 'hours of age', '85.5 to < 136.8', '136.8 to < 205.2', '205.2 to < 324.9', '> 324.9', '48 to < 72', '8.5 to < 13', '13 to < 15', '15 to < 22', '> 22', 'hours of age', '145.35 to < 222.3', '222.3 to < 256.5', '256.5 to < 376.2', '376.2', '72 hours to < 7', '11 to < 16', '16 to < 18', '18 to < 24', '> 24', 'days of age', '188. 1 to < 273.6', '273.6 to < 307.8', '307.8 to < 410.4', '> 410.4', '7 to 28 days of', '5 to < 10', '10 to < 20', '20 to < 25', ' 25', 'age', '85.5 to < 171', '171 to < 342', '342 to < 427.5', '> 427.5', '(breast feeding)', '151']['2017N331008_06', 'CONFIDENTIAL', '208090', 'PARAMETER', 'GRADE', 'GRADE', 'GRADE 3', 'GRADE 4', '1', '2', 'SEVERE', 'POTENTIALLY', 'MILD', 'MODERATE', 'LIFE-', 'THREATENIN', '7 to 28 days of', '1.1 to < 1.6 x ULN', '1.6 to < 2.6 x ULN', '2.6 to < 5.0 x ULN', '> 5.0 x ULN', 'age', '(not breast', 'feeding)', 'Preterm', 'Same as for Total', 'Same as for Total', 'Same as for Total', 'Same as for Total', 'Neonate 20', 'Bilirubin, High,', 'Bilirubin, High,', 'Bilirubin, High,', 'Bilirubin, High,', 'Term Neonate', 'Term Neonate', 'Term Neonate', 'Term Neonate', '35 to < 37', '(based', '(based', '(based', '(based', 'weeks', 'gestational', 'on days of age).', 'on days of age).', 'on days of age).', 'on days of age).', 'age', '32 to < 35', 'NA', 'NA', '10 to < 14', '> 14', 'weeks', '171 to < 239.4', '> 239.4', 'gestational age', 'and', '< 7 days of age', '28 to < 32', 'NA', 'NA', '6 to < 10', ' 10', 'weeks', '102.6 to < 171', ' 171', 'gestational age', 'and', '< 7 days of age', '< 28 weeks', 'NA', 'NA', '5to < 8', '8', 'gestational age', '85.5 to < 136.8', '136.8', 'and', '< 7 days of age', '7 to 28 days of', '5 to < 10', '10 to < 20', '20 to < 25', '> 25', 'age', '85.5 to < 171', '171 to < 342', '342 to < 427.5', '427.5', '(breast feeding)', '7 to 28 days of', '1.1 to < 1.6 X ULN', '1.6 to < 2.6 X ULN', '2.6 to < 5.0 x ULN', '> 5.0 X ULN', 'age', '(not breast', 'feeding)', '18', 'Severity grading for total bilirubin in neonates is complex because of rapidly changing total bilirubin', 'normal ranges in the first week of life followed by the benign phenomenon of breast milk jaundice after', 'the first week of life. Severity grading in this appendix corresponds approximately to cut-offs for', 'indications for phototherapy at grade 3 and for exchange transfusion at grade 4.', 'A laboratory value of 1 mg/dL is equivalent to 17.1 mol/L.', '20', 'Definitions: Term is defined as > 37 weeks gestational age; near-term, as > 35 weeks gestational age;', 'preterm, as < 35 weeks gestational age; and neonate, as 0 to 28 days of age.', 'Reference', 'U.S. Department of Health and Human Services, National Institutes of Health, National', 'Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS', '(DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version', '2.1. Mar 2017. Available from: https://rsc.tech-res.com/docs/default-source/safety/daids-', 'ae-grading-table-mar2017.pdf (date accessed: 24 Jan 2018).', '152']\n\n###\n\n", "completion": "END"}